To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
HR 10359 · In committee · last action September 14, 2026
Plain-language summary not yet available.
Associated votes
No votes recorded against this bill yet — vote coverage is a work in progress.
View official record on congress.gov